We are live on ! Find out more
FULC icon

Fulcrum Therapeutics
FULC

39 hedge funds and large institutions have $105M invested in Fulcrum Therapeutics in 2019 Q3 according to their latest regulatory filings, with 39 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

68.15% more ownership

Funds ownership: 0% → 68.15% (+68%)

Holders
39
Holders Change
+39
Holders Change %
–
% of All Funds
0.86%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
39
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TGI
TRV GP III
Massachusetts
+$66M
2
TGI
TRV GP IV
Massachusetts
+$25.9M
3
FCMI
Foresite Capital Management IV
California
+$18.7M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$16.5M
5
CC
Casdin Capital
New York
+$9.34M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
TGI
1
TRV GP III
Massachusetts
$39.6M +$66M +5,962,202 New
TGI
2
TRV GP IV
Massachusetts
$15.6M +$25.9M +2,343,154 New
FCMI
3
Foresite Capital Management IV
California
$11.2M +$18.7M +1,687,500 New
Fidelity Investments
4
Fidelity Investments
Massachusetts
$9.44M +$16.5M +1,492,884 New
CC
5
Casdin Capital
New York
$5.61M +$9.34M +844,285 New
AI
6
Alphabet Inc
California
$4.74M +$7.9M +714,285 New
PA
7
Perceptive Advisors
New York
$3.98M +$6.64M +600,000 New
AllianceBernstein
8
AllianceBernstein
Tennessee
$3.38M +$5.64M +509,369 New
HMC
9
Harvard Management Company
Massachusetts
$2.73M +$4.54M +410,714 New
Millennium Management
10
Millennium Management
New York
$2.06M +$3.44M +311,070 New
Bessemer Group
11
Bessemer Group
New Jersey
$1.9M +$3.16M +285,714 New
Alyeska Investment Group
12
Alyeska Investment Group
Illinois
$998K +$1.66M +150,265 New
FAM
13
Fred Alger Management
New York
$711K +$1.19M +107,138 New
LCM
14
Laurion Capital Management
New York
$629K +$1.05M +94,752 New
BlackRock
15
BlackRock
New York
$628K +$1.05M +94,600 New
PIM
16
Platinum Investment Management
Australia
$498K +$830K +75,000 New
Northern Trust
17
Northern Trust
Illinois
$353K +$589K +53,211 New
BM
18
Brandywine Managers
Delaware
$197K +$329K +29,700 New
Goldman Sachs
19
Goldman Sachs
New York
$185K +$308K +27,871 New
Geode Capital Management
20
Geode Capital Management
Massachusetts
$184K +$307K +27,791 New
Vanguard Group
21
Vanguard Group
Pennsylvania
$106K +$177K +15,997 New
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$89K +$148K +13,397 New
Victory Capital Management
23
Victory Capital Management
Texas
$78K +$130K +11,776 New
FT
24
Fiduciary Trust
Massachusetts
$66K +$111K +10,000 New
California State Teachers Retirement System (CalSTRS)
25
California State Teachers Retirement System (CalSTRS)
California
$47K +$78.3K +7,074 New
1
2

FULC Hedge Fund Activity: Q3 2019 in Review

39 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Fulcrum Therapeutics (FULC) for Q3 2019, worth a combined $105M.

Buyers outnumbered sellers: 39 funds opened new FULC positions and 0 closed out — a net gain of 39 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was TRV GP III, opening a new position worth an estimated $66M.

  • 39 institutional investors held Fulcrum Therapeutics (FULC) as of Q3 2019, up from 0 in Q2 2019.
  • Funds reported $105M of Fulcrum Therapeutics stock for Q3 2019.
  • 39 funds opened new Fulcrum Therapeutics positions in Q3 2019 and 0 closed out, a net change of +39 holders.
  • The largest Fulcrum Therapeutics buyer in Q3 2019 was TRV GP III, an estimated $66M added.

Based on aggregated 13F filings for Q3 2019.